ADAM12 and neoplasm: Moreover, no correlation was found between serum levels of ADAM12 and tumor cellularity (scored by a pathologist) or the keratin positive fraction (epithelium, scored with the image analysis pipeline of the IHC-classifier) (Additional file 1: Fig. S4), suggesting that serum ADAM12 does not associate with stromal abundance per se but specifically informs on its activation status.